Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction
- PMID: 38388424
- PMCID: PMC10993038
- DOI: 10.1523/JNEUROSCI.1610-23.2024
Nacc1 Mutation in Mice Models Rare Neurodevelopmental Disorder with Underlying Synaptic Dysfunction
Abstract
A missense mutation in the transcription repressor Nucleus accumbens-associated 1 (NACC1) gene at c.892C>T (p.Arg298Trp) on chromosome 19 causes severe neurodevelopmental delay ( Schoch et al., 2017). To model this disorder, we engineered the first mouse model with the homologous mutation (Nacc1+/R284W ) and examined mice from E17.5 to 8 months. Both genders had delayed weight gain, epileptiform discharges and altered power spectral distribution in cortical electroencephalogram, behavioral seizures, and marked hindlimb clasping; females displayed thigmotaxis in an open field. In the cortex, NACC1 long isoform, which harbors the mutation, increased from 3 to 6 months, whereas the short isoform, which is not present in humans and lacks aaR284 in mice, rose steadily from postnatal day (P) 7. Nuclear NACC1 immunoreactivity increased in cortical pyramidal neurons and parvalbumin containing interneurons but not in nuclei of astrocytes or oligodendroglia. Glial fibrillary acidic protein staining in astrocytic processes was diminished. RNA-seq of P14 mutant mice cortex revealed over 1,000 differentially expressed genes (DEGs). Glial transcripts were downregulated and synaptic genes upregulated. Top gene ontology terms from upregulated DEGs relate to postsynapse and ion channel function, while downregulated DEGs enriched for terms relating to metabolic function, mitochondria, and ribosomes. Levels of synaptic proteins were changed, but number and length of synaptic contacts were unaltered at 3 months. Homozygosity worsened some phenotypes including postnatal survival, weight gain delay, and increase in nuclear NACC1. This mouse model simulates a rare form of autism and will be indispensable for assessing pathophysiology and targets for therapeutic intervention.
Keywords: EEG; NACC1; autism; seizure; synapse; transcriptomics.
Copyright © 2024 the authors.
Conflict of interest statement
K.K.-G. spouse owns <0.1% stock in the following companies: Advanced Microdevices, Aveo Pharmaceuticals, Boston Scientific, Bristol-Myers Squibb, Cisco Systems, Fate Therapeutics, GE Healthcare Life Sciences, Generex Biotechnology, Idera Pharmaceuticals, Nante Health, Neurometrics, NuGenerex, Repligen, Sesen Bio, T2 Biosystems, and Vericel. The other authors declare no competing financial interests.
Similar articles
-
Hyperkinetic Movement Disorder Caused by the Recurrent c.892C>T NACC1 Variant.Mov Disord Clin Pract. 2024 Jun;11(6):708-715. doi: 10.1002/mdc3.14051. Epub 2024 May 2. Mov Disord Clin Pract. 2024. PMID: 38698576 Free PMC article.
-
An overview of the co-transcription factor NACC1: Beyond its pro-tumor effects.Life Sci. 2024 Jan 1;336:122314. doi: 10.1016/j.lfs.2023.122314. Epub 2023 Nov 27. Life Sci. 2024. PMID: 38030057 Review.
-
An intellectual-disability-associated mutation of the transcriptional regulator NACC1 impairs glutamatergic neurotransmission.Front Mol Neurosci. 2023 Jul 14;16:1115880. doi: 10.3389/fnmol.2023.1115880. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37533751 Free PMC article. Review.
-
A New Case of de novo Variant c.892C>T (p.Arg298Trp) in NACC1: A First Case Report From China.Front Pediatr. 2021 Nov 15;9:754261. doi: 10.3389/fped.2021.754261. eCollection 2021. Front Pediatr. 2021. PMID: 34869110 Free PMC article.
-
A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay.Am J Hum Genet. 2017 Feb 2;100(2):343-351. doi: 10.1016/j.ajhg.2016.12.013. Epub 2017 Jan 26. Am J Hum Genet. 2017. PMID: 28132692 Free PMC article.
References
-
- Ammanuel S, Chan WC, Adler DA, Lakshamanan BM, Gupta SS, Ewen JB, Johnston MV, Marcus CL, Naidu S, Kadam SD (2015) Heightened delta power during slow-wave-sleep in patients with Rett syndrome associated with poor sleep efficiency. PLoS One 10:e0138113. 10.1371/journal.pone.0138113 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials